The Health and Economic Benefits of Influenza Vaccination for Healthy and At-Risk Persons Aged 65 to 74 Years

被引：0
|
作者：
Kristin L. Nichol
Michael Goodman
机构：
[1] University of Minnesota and Minneapolis VA Medical Center (111),
[2] Health Partners Research Foundation,undefined
来源：
PharmacoEconomics | 1999年 / 16卷
关键词：
Influenza; Adis International Limited; Influenza Vaccine; Influenza Vaccination; Healthy Person;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: The objective of this study was to assess the health and economic benefits of influenza vaccination in both healthy and at-risk seniors aged 65 to 74 years.
引用
收藏
页码：63 / 71
页数：8
相关论文
共 43 条
  • [21] Barriers and facilitators to influenza vaccination among high-risk groups aged less than 65 years - views from general practitioners and practice nurses
    Zwar, Nicholas
    Hasan, Iqbal
    Harris, Mark
    Traynor, Vanessa
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2007, 31 (06) : 558 - 561
  • [22] Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data
    Jason M Nagata
    Isabel Hernández-Ramos
    Anand Sivasankara Kurup
    Daniel Albrecht
    Claudia Vivas-Torrealba
    Carlos Franco-Paredes
    BMC Public Health, 13
  • [23] Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data
    Nagata, Jason M.
    Hernandez-Ramos, Isabel
    Kurup, Anand Sivasankara
    Albrecht, Daniel
    Vivas-Torrealba, Claudia
    Franco-Paredes, Carlos
    BMC PUBLIC HEALTH, 2013, 13
  • [24] Influenza vaccine uptake among at-risk adults (aged 16-64 years) in the UK: a retrospective database analysis
    Oakley, Simon
    Bouchet, Julien
    Costello, Paul
    Parker, James
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [25] Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons
    Nichol, KL
    Nordin, J
    Mullooly, J
    VACCINE, 2006, 24 (10) : 1562 - 1568
  • [26] Modelling the population effectiveness of the national seasonal influenza vaccination programme in Scotland: The impact of targeting all individuals aged 65 years and over
    Corson, Stephen
    Robertson, Chris
    Reynolds, Arlene
    McMenamin, Jim
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2019, 13 (04) : 354 - 363
  • [27] Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older
    Honkanen, PO
    Keistinen, T
    Miettinen, L
    Herva, E
    Sankilampi, U
    Läärä, E
    Leinonen, M
    Kivelä, SL
    Mäkela, PH
    VACCINE, 1999, 17 (20-21) : 2493 - 2500
  • [28] "The flu ... is a little more complicated than a cold": Knowledge, beliefs, and practices related to influenza and influenza vaccination among at-risk populations and health professionals in Peru
    Garcia, Patricia J.
    George, Paul E.
    Romero, Candice
    Soto, Giselle
    Carcamo, Cesar
    Bayer, Angela M.
    VACCINE, 2020, 38 (48) : 7688 - 7695
  • [29] Economic and Health impact of influenza vaccination with adjuvant MF59 in population over 64 years in Spain
    Perez-Rubio, Alberto
    Maria Eiros, Jose
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2018, 31 (01) : 43 - 52
  • [30] Influenza Vaccination Among Adults 65 Years or Older: A 2009-2010 Community Health Survey in the Honam Region of Korea
    Ryu, So Yeon
    Kim, So Hui
    Park, Hyung Su
    Park, Jong
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2011, 8 (11) : 4197 - 4206
12345